Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0K4CQ
|
|||
Former ID |
DAP000503
|
|||
Drug Name |
Indecainide
|
|||
Synonyms |
Indecainida; Indecainidum; Ricainid; Ricainide; Indecainida [Spanish]; Indecainide [INN]; Indecainidum [Latin]; Decabid (TN); LY-135837; 9-(3-((1-methylethyl)amino)propyl)-9H-fluorene-9-carboxamide; 9-(3-(Isopropylamino)propyl))fluorene-9-carboxamide; 9-(3-(Isopropylamino)propyl)-9-fluorenylcarboxamid; 9-[3-(propan-2-ylamino)propyl]fluorene-9-carboxamide
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Dysrhythmias [ICD-11: BC9Z; ICD-9: 427] | Approved | [1] | |
Therapeutic Class |
Antidysrhythmic Agents
|
|||
Company |
Eli Lilly And Co
|
|||
Structure |
Download2D MOL |
|||
Formula |
C20H24N2O
|
|||
Canonical SMILES |
CC(C)NCCCC1(C2=CC=CC=C2C3=CC=CC=C31)C(=O)N
|
|||
InChI |
1S/C20H24N2O/c1-14(2)22-13-7-12-20(19(21)23)17-10-5-3-8-15(17)16-9-4-6-11-18(16)20/h3-6,8-11,14,22H,7,12-13H2,1-2H3,(H2,21,23)
|
|||
InChIKey |
UCEWGESNIULAGX-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 74517-78-5
|
|||
PubChem Compound ID | ||||
PubChem Substance ID | ||||
ChEBI ID |
CHEBI:135314
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Voltage-gated sodium channel alpha Nav1.5 (SCN5A) | Target Info | Blocker | [2] |
KEGG Pathway | Adrenergic signaling in cardiomyocytes | |||
Pathwhiz Pathway | Muscle/Heart Contraction | |||
Reactome | Interaction between L1 and Ankyrins | |||
WikiPathways | SIDS Susceptibility Pathways | |||
Cardiac Progenitor Differentiation |
References | Top | |||
---|---|---|---|---|
REF 1 | FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 019693. | |||
REF 2 | Electrophysiological studies of indecainide hydrochloride, a new antiarrhythmic agent, in canine cardiac tissues. J Cardiovasc Pharmacol. 1984 Jul-Aug;6(4):614-21. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.